The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells.
about
Overcoming resistance to BRAF inhibitors.Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors.RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas.
P2860
The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The BRAF Inhibitor Vemurafenib ...... F-Mutant Human Melanoma Cells.
@en
type
label
The BRAF Inhibitor Vemurafenib ...... F-Mutant Human Melanoma Cells.
@en
prefLabel
The BRAF Inhibitor Vemurafenib ...... F-Mutant Human Melanoma Cells.
@en
P2093
P2860
P1476
The BRAF Inhibitor Vemurafenib ...... F-Mutant Human Melanoma Cells.
@en
P2093
Harold G Parkes
Maria Falck Miniotis
Martin O Leach
Mounia Beloueche-Babari
Richard Marais
Slawomir Wantuch
P2860
P304
P356
10.1158/1535-7163.MCT-16-0068
P577
2016-10-07T00:00:00Z